$Adicet Bio (ACET.US)$Revenue has fluctuated and increased o...
$Adicet Bio(ACET.US$Revenue has fluctuated and increased over the past 5 years, and operating profit and net profit losses have continued to expand rapidly. Revenue returned to zero in 2023Q1, and losses continued to expand. Currently, there is no investment value in sight.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
aksla : this class of GD drug doesn’t seem working